soul trial oral semaglutide cardiovascular outcomes 2024 results mace reduction Shows 14% in in Adults with T2D, ASCVD, and/or CKD: Topline from Phase 3 SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




























![Dex [PAL] (Nintendo Switch) Option:Neuf](https://cdn.shopify.com/s/files/1/0037/2444/3737/files/DEX.jpg?v=1763481793)